IRIS
BELLOCCHI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.746
AS - Asia 1.949
EU - Europa 1.663
SA - Sud America 321
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 15.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.677
SG - Singapore 1.004
IT - Italia 373
CN - Cina 336
BR - Brasile 272
RU - Federazione Russa 269
HK - Hong Kong 206
DE - Germania 186
VN - Vietnam 172
SE - Svezia 129
UA - Ucraina 117
IE - Irlanda 112
FR - Francia 111
PL - Polonia 94
FI - Finlandia 82
GB - Regno Unito 78
JP - Giappone 53
CA - Canada 38
KR - Corea 38
IN - India 33
NL - Olanda 30
AR - Argentina 21
ID - Indonesia 20
MX - Messico 20
BE - Belgio 18
AT - Austria 15
BD - Bangladesh 15
CZ - Repubblica Ceca 14
ES - Italia 13
TR - Turchia 12
ZA - Sudafrica 11
UZ - Uzbekistan 10
IQ - Iraq 9
CH - Svizzera 6
EC - Ecuador 6
CO - Colombia 5
PE - Perù 5
CL - Cile 4
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
PK - Pakistan 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
KZ - Kazakistan 3
MN - Mongolia 3
PY - Paraguay 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
CM - Camerun 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.729
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.879
Wilmington 2.720
Houston 2.447
Singapore 616
Fairfield 413
Ashburn 306
Chandler 277
San Jose 274
Ann Arbor 232
Hong Kong 202
Rome 189
Seattle 181
Beijing 156
Cambridge 136
Dublin 104
New York 102
Santa Clara 102
Jacksonville 98
Council Bluffs 85
Medford 83
The Dalles 80
Los Angeles 70
Creede 69
Kraków 69
Ho Chi Minh City 59
Tokyo 50
Helsinki 46
Dearborn 45
Hanoi 44
Moscow 43
Milan 38
Lawrence 37
Buffalo 36
Dallas 35
Munich 35
São Paulo 28
San Diego 26
Colorado Springs 22
Nuremberg 22
Orem 19
Warsaw 19
Brussels 18
Frankfurt am Main 18
Mülheim 18
Lauterbourg 17
London 17
Zhengzhou 15
Brooklyn 14
Chicago 14
Jakarta 14
Montreal 13
Denver 12
Menlo Park 12
Mountain View 12
Stockholm 12
Redondo Beach 11
Chennai 10
Florence 10
Phoenix 10
Redwood City 10
Brno 9
Guangzhou 9
Mumbai 9
North Bergen 9
Seoul 9
Columbus 8
Johannesburg 8
Toronto 8
Amsterdam 7
Atlanta 7
Boardman 7
Boston 7
Falls Church 7
Lappeenranta 7
Magenta 7
Manchester 7
Mexico City 7
Tashkent 7
Brasília 6
Da Nang 6
Palo Alto 6
Paris 6
Rio de Janeiro 6
San Francisco 6
Vienna 6
Cedarhurst 5
Dong Ket 5
Norwalk 5
Olomouc 5
Shanghai 5
University Park 5
Zurich 5
Belo Horizonte 4
Binasco 4
Bologna 4
Cagliari 4
Camaçari 4
Changsha 4
Detroit 4
Haiphong 4
Totale 12.999
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 533
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso 504
Virologic correlates of adherence to antiretroviral medications and therapeutic failure 500
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 493
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 487
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 484
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 484
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 473
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 471
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors 471
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 465
Population variation analysis at nine loci containing expressed trinucleotide repeats 464
Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage 444
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme 443
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy 443
Dynamics of NRTI resistance mutations during therapy interruption 435
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 434
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy 426
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir 421
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 407
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B 407
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors 406
Temporal change in the use of genotypic resistance testing over the years 1999--2003 405
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 395
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 384
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 307
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 257
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 230
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 201
Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation 161
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 151
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 141
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 130
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 124
Characterization of HBV and HCV minority quasispecies by ultra-deep pyrosequencing analysis: impact on pathogenicity and response to antiviral drugs 115
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 110
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 109
HHV-8 genetic diversification and its impact on severe clinical presentation of associated diseases 108
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 107
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 104
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 101
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 100
First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus 96
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 89
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 87
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 84
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 84
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 83
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 78
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients 74
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. 71
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 69
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 64
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort 64
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure 63
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors 62
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era 61
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units 54
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy 54
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure 51
Using a database of genotype resistance tests to describe characteristics related to detection of the multinucleoside resistance-associated Q151M mutation. 49
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 48
Long-term evaluation of the effect of genotype-based antiretroviral therapy upon virological, immunological, and clinical parameters 45
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase 42
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors 42
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen 41
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation 40
Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid 11
null 3
Totale 16.021
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021170 0 0 0 0 0 0 0 0 0 69 69 32
2021/2022570 42 45 33 36 20 35 26 25 123 45 24 116
2022/2023895 77 66 52 88 47 131 38 224 51 69 41 11
2023/2024323 55 5 27 16 30 85 7 11 12 18 3 54
2024/20251.647 75 357 177 144 43 80 170 76 164 131 100 130
2025/20262.699 309 121 277 311 264 110 368 394 332 213 0 0
Totale 16.021